Literature DB >> 12564574

Blood pressure and other cardiovascular risk factors among treated hypertensives in Swedish primary health care.

Jan Cederholm1, Peter M Nilsson, Carl-Peter Anderberg, Lars Fröberg, Ulla Petersson.   

Abstract

OBJECTIVE: To evaluate antihypertensive treatment and other cardiovascular risk factors in primary health care.
DESIGN: Cross-sectional survey of consecutive patients with treated hypertension in 1999.
SETTING: 17 primary care centres in Sweden.
SUBJECTS: 512 patients (mean age 67; SD 11 years). MAIN OUTCOME MEASURES: Antihypertensive treatment, cardiovascular risk factors.
RESULTS: Patients with high diastolic BP (> or = 100 mmHg) and systolic BP (> 180 mmHg) values were few. The proportions with diastolic BP < 90, BP < 160/95 and < 140/90 mmHg were 64%, 54% and 15%. Mono-therapy was given in 51%, and > or = 3 drugs in 13%. Hypertensives with hyperlipidaemia were 42%, and only 26% of them were given lipid-lowering drugs, mainly statins, 21%. Smokers were 10%, 23% had diabetes, and many had overweight BMI = 25 kg/m2, 72%.
CONCLUSION: Although two-thirds had diastolic BP < 90 mmHg, few had BP below the current treatment target < 140/90 mmHg. More than half of the hypertensives had at least one additional cardiovascular risk factor, and these hypertensives also had low proportions within several current treatment targets of hypertension and hyperlipidaemia, implying a need for intensified multiple risk factor intervention.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12564574     DOI: 10.1080/028134302321004881

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  1 in total

1.  Cardiovascular risk factor treatment targets and renal complications in high risk vascular patients: a cohort study.

Authors:  Sharmini Selvarajah; Yolanda van der Graaf; Frank L J Visseren; Michiel L Bots
Journal:  BMC Cardiovasc Disord       Date:  2011-07-05       Impact factor: 2.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.